Lupin Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

Lupin yıllık ortalama 28.8% oranında kazançlarını artırırken, Pharmaceuticals sektöründe kazançlar growing at 13.4% annual. Gelirler growing yılda ortalama 3.9% oranında artmaktadır. Lupin'in özkaynak karlılığı 15.9% ve net marjı 10.9%'dir.

Anahtar bilgiler

28.8%

Kazanç büyüme oranı

28.7%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi17.5%
Gelir büyüme oranı3.9%
Özkaynak getirisi15.9%
Net Marj10.9%
Sonraki Kazanç Güncellemesi07 Nov 2024

Yakın geçmiş performans güncellemeleri

Recent updates

With EPS Growth And More, Lupin (NSE:LUPIN) Makes An Interesting Case

Sep 17
With EPS Growth And More, Lupin (NSE:LUPIN) Makes An Interesting Case

Lupin Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 09
Lupin Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Unpleasant Surprises Could Be In Store For Lupin Limited's (NSE:LUPIN) Shares

Aug 01
Unpleasant Surprises Could Be In Store For Lupin Limited's (NSE:LUPIN) Shares

Lupin Limited (NSE:LUPIN) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Jul 13
Lupin Limited (NSE:LUPIN) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Lupin's (NSE:LUPIN) Dividend Will Be Increased To ₹8.00

Jul 12
Lupin's (NSE:LUPIN) Dividend Will Be Increased To ₹8.00

These 4 Measures Indicate That Lupin (NSE:LUPIN) Is Using Debt Safely

Jun 15
These 4 Measures Indicate That Lupin (NSE:LUPIN) Is Using Debt Safely

Analysts Are Updating Their Lupin Limited (NSE:LUPIN) Estimates After Its Annual Results

May 09
Analysts Are Updating Their Lupin Limited (NSE:LUPIN) Estimates After Its Annual Results

With EPS Growth And More, Lupin (NSE:LUPIN) Makes An Interesting Case

May 08
With EPS Growth And More, Lupin (NSE:LUPIN) Makes An Interesting Case

Investor Optimism Abounds Lupin Limited (NSE:LUPIN) But Growth Is Lacking

Apr 20
Investor Optimism Abounds Lupin Limited (NSE:LUPIN) But Growth Is Lacking

Here's Why Lupin (NSE:LUPIN) Can Manage Its Debt Responsibly

Mar 03
Here's Why Lupin (NSE:LUPIN) Can Manage Its Debt Responsibly

Earnings Beat: Lupin Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 10
Earnings Beat: Lupin Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Lupin Limited's (NSE:LUPIN) Share Price Could Signal Some Risk

Jan 19
Lupin Limited's (NSE:LUPIN) Share Price Could Signal Some Risk

Is Lupin (NSE:LUPIN) Using Too Much Debt?

Nov 10
Is Lupin (NSE:LUPIN) Using Too Much Debt?

Is Lupin (NSE:LUPIN) Using Too Much Debt?

Jun 23
Is Lupin (NSE:LUPIN) Using Too Much Debt?

Here's Why Lupin (NSE:LUPIN) Can Manage Its Debt Responsibly

Mar 24
Here's Why Lupin (NSE:LUPIN) Can Manage Its Debt Responsibly

Lupin's (NSE:LUPIN) Dividend Is Being Reduced To ₹4.00

Jul 08
Lupin's (NSE:LUPIN) Dividend Is Being Reduced To ₹4.00

Gelir ve Gider Dağılımı

Lupin nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NSEI:LUPIN Gelir, gider ve kazançlar (INR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 24207,97122,63537,1960
31 Mar 24200,10819,14535,9300
31 Dec 23194,80117,91034,6470
30 Sep 23186,04913,31433,3940
30 Jun 23177,1199,71432,5040
31 Mar 23166,4174,30131,8450
31 Dec 22160,946-3,23931,0900
30 Sep 22159,33368230,8890
30 Jun 22158,791-21,59630,7580
31 Mar 22164,055-15,28030,8100
31 Dec 21163,052-5,49730,1510
30 Sep 21161,616-6,57029,7800
30 Jun 21159,05316,52129,0470
31 Mar 21151,63012,16529,1460
31 Dec 20152,26011,45830,3680
30 Sep 20149,777-1,60930,7070
30 Jun 20150,249-5,57231,4560
31 Mar 20153,748-3,99530,7440
31 Dec 19174,693-4,42835,4290
30 Sep 19176,8923,13834,9590
30 Jun 19172,8067,06834,3940
31 Mar 19146,6465,12129,6580
31 Dec 18163,114-4,66532,8750
30 Sep 18157,822-93131,7210
30 Jun 18157,82996031,0330
31 Mar 18157,7652,51330,7180
31 Dec 17159,23314,15030,3610
30 Sep 17164,30618,26430,7170
30 Jun 17167,69320,33630,5670
31 Mar 17173,67425,57530,4190
31 Dec 16173,91029,35128,2490
30 Sep 16164,55828,26526,3720
30 Jun 16154,91825,84124,5760
31 Mar 16141,31622,60722,9310
31 Dec 15131,05520,10636,5921,682
30 Sep 15127,27320,82335,4671,682
30 Jun 15125,79423,03534,6141,682
31 Mar 15127,70024,03218,5700
31 Dec 14128,12424,09232,7091,311
30 Sep 14126,56722,83932,3371,311
30 Jun 14121,51220,60131,6301,311
31 Mar 14112,86618,36430,8081,311
31 Dec 13107,51916,91528,011890

Kaliteli Kazançlar: LUPIN yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: LUPIN 'nin mevcut net kar marjları (10.9%) geçen yılın (5.5%) sinden daha yüksektir.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: LUPIN şirketinin kazançları son 5 yılda yılda 28.8% oranında önemli ölçüde arttı.

Büyüme Hızlandırma: LUPIN 'un son bir yıldaki kazanç büyümesi ( 133% ) 5 yıllık ortalamasını (yıllık 28.8% ) aşıyor.

Kazançlar vs. Sektör: LUPIN geçen yılki kazanç büyümesi ( 133% ) Pharmaceuticals sektörünün 19.1% değerini aştı.


Özkaynak Getirisi

Yüksek ROE: LUPIN 'nin Özsermaye Getirisi ( 15.9% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin